Health TrialsbyHealthPanel

Cohort Study of Chronic Liver Disease Complicated by Sepsis

ConditionsCirrhosisSepsis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorThe Second Affiliated Hospital of Chongqing Medical University

About this trial

Study population: Patients with liver cirrhosis complicated by sepsis Observation indicators: Fluid resuscitation strategy, early dynamic indicators such as MAP Observation endpoint: 28-day all-cause mortality Study design: Retrospective cohort study

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Clinically or pathologically diagnosed with cirrhosis;

meets the Sepsis-3 diagnostic criteria.

Disqualifiers

Combined organ transplantation, active malignant tumors;

Pregnant or breastfeeding women;

Long-term use of immunosuppressants (non-steroidal);

Death or voluntary discharge within 24 hours of admission;

Trial population

Cirrhosis complicated by sepsis

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

28-day all-cause mortality in cirrhosis with sepsis

Time frame
Baseline and 28 days.

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

The Second Affiliated Hospital of Chongqing Medical University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: